Skip to main content

Department of Neurology research bulletin

The Department of Neurology research bulletin is updated monthly. Check back for the latest grants, awards, and high-impact publications. 

Grants and Awards

R01 | Post-stroke Cognitive Impairment and Dementia

Associate Professor, Ying Xian, M.D., Ph.D., received an R01 for “Post-stroke Cognitive Impairment and Dementia” from the NIH/NIA.

 

R01 | Understanding Degeneration in Neurons of the Inferior Olivary Nucleus

Professor, Vikram Shakkottai, M.D., Ph.D., received an R01 for “Understanding Degeneration in Neurons of the Inferior Olivary Nucleus” from NIH/NINDS. 

 

High Impact Publications

William Dauer, M.D., M.S., Samuel Pappas, Ph.D., and their collaborators published “TorsinA is essential for neuronal nuclear pore complex localization and maturation.” in Nature Cell Biology

Vikram Shakkottai, M.D., Ph.D., Samuel Pappas, Ph.D., and their collaborators published “Increased intrinsic membrane excitability is associated with olivary hypertrophy in spinocerebellar ataxia type 1.” in Human Molecular Genetics

Benjamin Greenberg, M.D., Nancy Monson, Ph.D., Linda Nguyen, M.D., and collaborators published “Astrocytic stress response is induced by exposure to astrocyte-binding antibodies expressed by plasmablasts from pediatric patients with acute transverse myelitis.” in the Journal of Neuroinflammation

Elan Louis, M.D., M.S., and his collaborators published “Purkinje Cell Dendritic Swellings: A Postmortem Study of Essential Tremor and Other Cerebellar Degenerative Disorders.” in Cerebellum.

Ying Xian, M.D., Ph.D., and his collaborators published “Twenty Years of Sustained Improvement in Quality of Care and Outcomes for Patients Hospitalized With Stroke or Transient Ischemic Attack: Data From The Get With The Guidelines-Stroke Program.” in Stroke AHA 

Evan Noch, M.D., Ph.D., and collaborators published “Cysteine induces mitochondrial reductive stress in glioblastoma through hydrogen peroxide production.” in Proceedings of the National Academy of Sciences, USA

Archive 2024

Grants and Awards

Peter Sguigna, M.D.

Peter Sguigna, M.D.

A Phase I Study of Circadian Focused Light Therapy for Fatigue Reduction in Progressive Multiple Sclerosis

Assistant Professor Peter Sguigna, M.D., received a grant for his study “A Phase I Study of Circadian Focused Light Therapy for Fatigue Reduction in Progressive Multiple Sclerosis” from the National Multiple Sclerosis Society. 

High-Impact Publications

Munro Cullum, Ph.D., and his collaborator published “Lingering Symptoms Following Sports-Related Brain Injury” in JAMA Network Open.

Kan Ding, M.D., Rong Zhang, Ph.D., and their collaborators published “Age-related smartphone use patterns among individuals with moderate-to-severe traumatic brain injury” in Brain Injury.

Ihab Hajjar, M.D., and his collaborators published “Perceived Stress is Associated with Alzheimer's Disease Cerebrospinal Fluid Biomarkers in African Americans with Mild Cognitive Impairment” in Advances in Alzheimer's Disease. 

Erica Jones, M.D., Mehari Gebreyohanns, M.D., DaiWai Olson, Ph.D., R.N., Nneka Ifejika, M.D., M.P.H., and their collaborators published “A qualitative study of barriers and facilitators to using tenecteplase to treat acute ischemic stroke” in the Journal of Stroke and Cerebrovascular Diseases. 

Elan Louis, M.D., M.S., and his collaborators pu lished “Reduced Bergmann glial process terminations and lateral appendages in essential tremor” in the Annals of Clinical and Translational Neurology.

Darryl Miles, M.D., Lana Harder, Ph.D., Brett Whittemore, M.D., Benjamin Greenberg, M.D., Cynthia Wang, M.D., and their collaborators published “Increased Intracranial Pressure in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease” in Neurology neuroimmunology & neuroinflammation.

Amber Salter, Ph.D., and her collaborators published “Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations” in Neurology.

Steven Vernino, M.D., Ph.D., Meredith Bryarly, M.D., Amber Salter, Ph.D., and their collaborators published “Randomized controlled trial of intravenous immunoglobulin for autoimmune postural orthostatic tachycardia syndrome (iSTAND)” in Clinical Autonomic Research.

 

Archive 2023

Grants and Awards

Kan Ding, M.D.

Kan Ding, M.D.

National Institute of Neurological Disorders and Stroke

Associate Professor, Kan Ding, M.D., received her R01 grant: “Cerebral Autoregulation, Brain Perfusion, and Neurocognitive Outcomes After Traumatic Brain Injury (CAPCOG-TBI)” 

Cognitive impairment after moderate to severe traumatic brain injury (msTBI) not only significantly affects the quality of life in individuals with msTBI, but also increases the possibility of late-life dementia. The goal of this study is to determine whether acute (< 1 week) cerebrovascular injury and its recovery within the first year postinjury measured by cerebral autoregulation and brain perfusion are associated with cognitive outcome at 12 months after msTBI. The results from this study will improve our understanding of cerebrovascular contributions to cognitive decline related to TBI and provide critical data to inform the development of strategies based on vascular mechanisms to improve cognition after msTBI.

Steven Vernino, M.D., Ph.D.

Steven Vernino, M.D., Ph.D.

Professor and Vice-Chair Steven Vernino, M.D., Ph.D., received his R01 grant: “Multimodality Deep Phenotyping of Postural Orthostatic Tachycardia Syndrome (POTS)”.

Postural orthostatic tachycardia syndrome (POTS) is a chronic disorder causing disabling symptoms and substantial loss of productivity. Not all POTS patients are the same, and the causes and significance of different subtypes are not known. For example, some patients may have abnormal regulation of their immune system while others may have problems with the response of their muscles to activity. Exercise training has been shown to be a beneficial treatment for POTS, but about 25% of patients are unable to complete the exercise program. Our research study will examine the different types of POTS by systematically and comprehensively studying a large diverse group of patients. This will include careful assessment of symptoms, blood tests, and heart structure as well as a detailed analysis of the muscle response to exercise. This study will be the first to define the full picture of different POTS subtypes and the relationship between these subtypes. Our studies will allow clinicians to better evaluate and individualize treatment and will guide future POTS research.

 

High-Impact Publications